New FDA Guidance Expands HUD Patient Limit
Executive Summary
Devices to treat diseases and conditions affecting many more Americans are eligible for Humanitarian Use Device status under a new guidance document.
You may also be interested in...
Final Guidance Clarifies HDE Process, ‘Probable Benefit’
The US FDA has finalized a guidance document on the humanitarian device exemption process. The revision brings the document in line with requirements of the 21st Century Cures Act.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.